ACORN BIOVENTURES 2, L.P. - 15 May 2025 Form 3 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role: 10%+ Owner
Signature: ACORN BIOVENTURES 2, L.P., By: Acorn Capital Advisors GP 2, LLC, its general partner, By: /s/ Anders Hove, Manager
Issuer symbol: OKUR
Transactions as of: 15 May 2025
Net transactions value: $0
Form type: 3
Filing time: 27 May 2025, 19:44:16 UTC
SEC: View on sec.gov

Reporting Owners (2)

Name	Relationship	Address	Signature	Signature date	CIK
ACORN BIOVENTURES 2, L.P.	10%+ Owner	420 LEXINGTON AVE., SUITE 2626, NEW YORK	ACORN BIOVENTURES 2, L.P., By: Acorn Capital Advisors GP 2, LLC, its general partner, By: /s/ Anders Hove, Manager	27 May 2025	0001876405
Acorn Capital Advisors GP 2, LLC	10%+ Owner	420 LEXINGTON AVE.,, SUITE 2626, NEW YORK	ACORN CAPITAL ADVISORS GP 2, LLC, By: /s/ Anders Hove, Manager	27 May 2025	0002070458

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OKUR	Common Stock						1,129,730	15 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held directly by Acorn Bioventures 2, L.P. ("Acorn 2"). Acorn Capital Advisors GP 2, LLC ("Acorn GP 2") is the general partner of Acorn 2. Anders Hove is the manager of Acorn GP 2. Each of Acorn GP 2 and Mr. Hove disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Content

Shares held directly by Acorn Bioventures 2, L.P. ("Acorn 2"). Acorn Capital Advisors GP 2, LLC ("Acorn GP 2") is the general partner of Acorn 2. Anders Hove is the manager of Acorn GP 2. Each of Acorn GP 2 and Mr. Hove disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.